AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Research agreement signed for testing of topical anti-herpes formulations.
2003 DEC 4 - (NewsRx.com & NewsRx.net) -- CytoGenix, Inc., (CYGX) has signed an agreement with the DermPharm division of DermTech International, Inc., a firm specializing in dermatology safety and efficacy testing with experience in the U.S. Food and Drug Administration (FDA) regulatory process and in conducting studies to characterize the kinetics of various topical delivery vehicles such as those for CytoGenix' anti-herpes formulation.
The CytoGenix product studies are designed to characterize human epidermal cell delivery and uptake of the gene silencing DNA topical formulation against herpes.
Yin Chen, chief scientist and vice president of research and development for CytoGenix, stated; "These studies of human skin kinetics will provide the data we need to ...
- CytoGenix Enters into a Supply Agreement with GE Healthcare for DNA Production...
- Press release article from: Business Wire March 23, 2006 700+ words
...Electric Company (NYSE:GE), and CytoGenix, Inc. (OTCBB:CYGX) have entered...agreement in which GE Healthcare will provide CytoGenix with DNA production reagents for use...vaccines and therapeutic compounds by CytoGenix. Under the terms of the agreement...
- CytoGenix, Inc. Receives Coverage and Rating by Independent Research Firm J.M....
- Press release article from: Business Wire August 1, 2002 700+ words
...BUSINESS WIRE)--Aug. 1, 2002 CytoGenix, Inc. (OTCBB:CYGX) J.M. Dutton...Associates has initiated research coverage of CytoGenix, Inc. with a Speculative Buy rating...and other leading financial portals. CytoGenix, Inc. is also featured in J.M. Dutton...
- CytoGenix, Inc. Board Appoints Industry Veteran Lex M. Cowsert, PhD as...
- Press release article from: Business Wire November 18, 2008 700+ words
HOUSTON -- CytoGenix, Inc. (OTCBB:CYGX) today announced...and Director significantly strengthens CytoGenix's management team as the Company enters...Dr. Cowsert will lead the team at CytoGenix to implement a stronger business and...
- CytoGenix and Aldevron Announce Positive Results of synDNA(TM) Hepatitis...
- Press release article from: Business Wire December 19, 2005 700+ words
HOUSTON & FARGO, N.D. -- CytoGenix, Inc. (OTCBB:CYGX) and Aldevron...positive results of a pilot study using CytoGenix synDNA(TM) as the active ingredient...pathogenic organisms. For this study, CytoGenix scientists prepared a synthetic DNA vaccine...
- CytoGenix Receives First Order for synDNA(TM).
- Press release article from: Business Wire March 30, 2006 700+ words
HOUSTON -- CytoGenix, Inc. (OTCBB:CYGX) announced receiving...research and clinical applications. CytoGenix and Aldevron have joined forces to meet...quantities of highly pure DNA. "The CytoGenix synDNA(TM) technology allows us to...
- CytoGenix synDNA(TM) HIV Vaccine Shows Robust Cellular Immune Response in...
- Press release article from: Business Wire December 11, 2006 700+ words
HOUSTON -- CytoGenix (OTCBB:CYGX) has demonstrated that...Yin Chen and Frederic Kendirgi at CytoGenix in collaboration with Lauren Hirao and...primates is a tremendous step forward for CytoGenix," commented Dr. Malcolm Skolnick...
- CytoGenix Inc. to Receive a Research Grant From National Health Institute/NIH.
- Press release article from: Business Wire March 26, 2002 700+ words
...BUSINESS WIRE)--March 26, 2002 CytoGenix Inc. (OTCBB:CYGX) announced today...This grant will support research both at CytoGenix and in the laboratory of our collaborator...is also one of the earliest members of CytoGenix's scientific advisory board (SAB...
- CytoGenix Announces Agreement with Taiwan Cobia Inc. to Develop DNA Vaccines...
- Press release article from: Business Wire March 5, 2008 700+ words
HOUSTON -- CytoGenix, Inc. (CYGX.OB) announced today...fish viruses. Under this Agreement, CytoGenix will develop DNA vaccines against selected...to health management of fish stocks. CytoGenix' synDNA[TM] technology has the capability...